ROCHESTER MEDICAL CORPORATION 4
4 · ROCHESTER MEDICAL CORPORATION · Filed Nov 18, 2013
Insider Transaction Report
Form 4
BOEHM DARNELL L
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2013-11-14$8.73/sh−10,000$87,300→ 0 totalExercise: $11.27From: 2009-02-03Exp: 2019-02-03→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2013-11-14$9.28/sh−16,000$148,480→ 0 totalExercise: $10.72From: 2011-01-27Exp: 2021-01-27→ Common Stock (16,000 underlying) - Disposition to Issuer
Common Stock
2013-11-14$20.00/sh−24,642$492,840→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2013-11-14$7.70/sh−40,000$308,000→ 0 totalExercise: $12.30From: 2006-11-21Exp: 2016-11-21→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2013-11-14$8.77/sh−10,000$87,700→ 0 totalExercise: $11.23From: 2008-02-06Exp: 2018-02-05→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2013-11-14$7.73/sh−12,000$92,760→ 0 totalExercise: $12.27From: 2010-01-28Exp: 2020-01-28→ Common Stock (12,000 underlying)
Footnotes (4)
- [F1]On November 14, 2013, in connection with the acquisition of Rochester Medical Corporation (the "Company") by C. R. Bard, Inc., a New Jersey corporation ("Bard") pursuant to the Agreement and Plan of Merger dated September 3, 2013 (the "Merger Agreement") among the Company, Bard and a wholly owned subsidiary of Bard, at the effective time of the merger contemplated by the Merger Agreement (the "Merger"), these shares of Company common stock were cancelled and converted into the right to receive a cash payment of $20.00 per share, without interest and less any applicable withholding taxes.
- [F2]Includes restricted stock awards.
- [F3]Pursuant to the Merger Agreement, upon the effectiveness of the Merger 10,642 shares of restricted stock were cancelled in exchange for the right to receive $20.00 per share, without interest and less any applicable withholding taxes.
- [F4]These options were 100% vested on date of grant. Pursuant to the Merger Agreement, upon the effectiveness of the Merger the vesting of these options was accelerated and they were cancelled in exchange for the right to receive a cash payment per option equal to the excess of $20.00 over the per share exercise price of the option.